查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1785939

全球心臟人工智慧監測與診斷市場

Cardiac Artificial Intelligence Monitoring and Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 202 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球心臟人工智慧監測和診斷市場規模將達到 57 億美元

全球心臟AI監測和診斷市場規模預計在2024年達到13億美元，預計在分析期內（2024-2030年）將以27.5%的複合年成長率成長，到2030年將達到57億美元。心臟AI監測和診斷硬體是本報告分析的細分市場之一，預計在分析期結束時，其複合年成長率將達到30.5%，達到33億美元。心臟AI監測和診斷軟體細分市場在分析期間的複合年成長率預計將達到25.0%。

美國市場規模估計為 3.466 億美元，中國市場預計複合年成長率為 25.9%

美國心臟人工智慧監測和診斷市場規模預計在2024年達到3.466億美元。預計在分析期間（2024-2030年），全球第二大經濟體中國市場的複合年成長率將達到25.9%，到2030年市場規模將達到8.504億美元。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為25.5%和23.4%。在歐洲，預計德國市場的複合年成長率約為18.7%。

全球心臟人工智慧監測和診斷市場—主要趨勢和促進因素摘要

為什麼心臟人工智慧監測和診斷的需求越來越大？

由於心血管疾病的發生率不斷上升、對早期精準檢測的需求日益成長，以及主導醫療解決方案的不斷進步，對心臟人工智慧監測和診斷的需求也日益成長。冠狀動脈疾病、心臟衰竭和心律不整等心臟病仍然是全球範圍內的主要死亡原因。傳統的診斷方法雖然有效，但往往需要耗時的解讀，並且容易出現人為錯誤。人工智慧監測系統和診斷工具正在透過提供更快、更準確、更即時的心臟健康狀況洞察，徹底改變心血管護理。

穿戴式醫療技術、遠端患者監護和人工智慧輔助影像的興起，使得心臟診斷更加便利、更具主動性。人工智慧驅動的心電圖解讀、心臟衰竭預測分析以及自動心律不整檢測，正在幫助臨床醫生做出明智的決策，同時減輕醫療服務提供者的負擔。此外，將人工智慧融入遠端保健和數位健康平台，可以實現早期療育，尤其是對高風險患者，從而減少住院治療並改善患者預後。隨著醫療保健系統向預測性和預防性心臟病學轉型，人工智慧主導的心臟診斷的應用預計將得到擴展。

科技進步如何改善心臟 AI 監測和診斷？

人工智慧、深度學習和穿戴式感測器技術的創新正在提高心臟監測和診斷的準確性、效率和可及性。其中最重要的進展之一是人工智慧增強心電圖 (ECG) 的開發，它能夠高精度地檢測複雜的心臟疾病，例如心房顫動、心室心搏過速和心肌梗塞。人工智慧驅動的心電圖演算法可以即時分析大量數據，減少診斷錯誤並提高早期檢出率。

另一項重大突破是將人工智慧融入心血管影像程序，例如超音波心動圖、心臟核磁共振和 CT血管造影術。人工智慧影像解決方案可幫助放射科醫師和心臟科醫師識別異常、量化心臟功能並更有效地評估冠狀動脈疾病。此外，穿戴式人工智慧心臟監測儀（如智慧型手錶和生物感測器）可提供持續、即時的心臟健康監測，在症狀變得嚴重之前提醒使用者和醫療保健提供者註意潛在風險。機器學習模型也正在開發中，以預測心臟病的進展並根據患者特定數據制定個人化治療計劃。隨著人工智慧技術的不斷發展，其在心臟護理中的作用將變得更加突出，提高準確性、效率和早期疾病檢測。

哪些市場趨勢推動了心臟 AI 監測和診斷產業的發展？

人工智慧在遠端醫療和遠端患者監護中的日益普及，是塑造心臟人工智慧市場最具影響力的趨勢之一。隨著虛擬醫療的興起，人工智慧驅動的心臟監測設備能夠在家中持續追蹤心臟健康狀況，減少頻繁就診的需求。這一趨勢對於管理慢性心臟疾病和高風險患者尤其重要，因為即時人工智慧分析可以在心律不整導致嚴重併發症之前檢測到它們。

影響市場成長的另一個關鍵趨勢是人工智慧在個人化醫療中的擴展。人工智慧主導的分析被用於根據個別患者數據量身定做治療計劃，並改善心臟病患者的治療效果。此外，製藥公司正在利用人工智慧最佳化心血管藥物研發，並將人工智慧進一步融入更廣泛的心臟護理生態系統。心臟病學巨量資料的興起，加上雲端基礎的人工智慧解決方案，使得醫療專業人員之間能夠無縫共用數據並進行即時協作，從而增強患者照護。隨著人工智慧診斷技術的不斷改進，其與醫院工作流程的整合度也不斷提高，人工智慧驅動的心臟監測正成為循環系統醫療保健的常態。

影響心臟 AI 監測和診斷市場未來發展的關鍵成長動力有哪些？

心臟人工智慧監測和診斷市場的成長受到多種關鍵因素的推動，包括心血管疾病盛行率的上升、人工智慧演算法的進步以及數位醫療基礎設施的不斷擴展。其中一個關鍵成長要素是心臟病負擔的增加，這推動了對早期檢測、預測分析和持續監測解決方案的需求。人工智慧主導的診斷工具可以縮短診斷心臟病所需的時間，從而加快干預速度並改善患者預後。

影響市場的另一個關鍵促進因素是醫療機構對人工智慧診斷解決方案的監管核准和採用日益增多。各國政府和監管機構已經認知到人工智慧在心臟病學領域的潛力，從而加大了對人工智慧研究和數位醫療政策的投資。此外，人工智慧穿戴裝置的價格實惠、普及性強，加上人工智慧可解釋性的提升，使得心臟監測更方便患者使用且更具可擴展性。隨著人工智慧與醫療保健的融合不斷加速，心臟人工智慧監測和診斷市場預計將迎來顯著成長，並徹底改變全球心臟病的檢測、預防和管理。

部分

產品類型（心臟AI監測和診斷硬體、心臟AI監測和診斷軟體、心臟AI監測和診斷服務）、類型（心臟診斷、心臟監測）、應用（心律不整應用、中風應用、缺血性心臟疾病應用、狹窄應用、其他應用）、最終用途（醫院最終用途、專科診所最終用途、診斷中心最終用途、其他最終用途）

受訪公司範例

  • Abbott Laboratories
  • Aidoc Medical Ltd.
  • AliveCor, Inc.
  • Arterys Inc.
  • Boston Scientific Corporation
  • CardiAI
  • Cardio Diagnostics
  • Cardiologs Technologies
  • Cleerly, Inc.
  • DiA Imaging Analysis
  • Eko Health Inc.
  • GE HealthCare Technologies Inc.
  • HeartVista, Inc.
  • Idoven
  • iRhythm Technologies, Inc.
  • Koninklijke Philips NV
  • Medtronic plc
  • RSIP Vision
  • Siemens Healthineers AG
  • Tempus AI, Inc.

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP29823

Global Cardiac Artificial Intelligence Monitoring and Diagnostics Market to Reach US$5.7 Billion by 2030

The global market for Cardiac Artificial Intelligence Monitoring and Diagnostics estimated at US$1.3 Billion in the year 2024, is expected to reach US$5.7 Billion by 2030, growing at a CAGR of 27.5% over the analysis period 2024-2030. Cardiac AI Monitoring & Diagnostics Hardware, one of the segments analyzed in the report, is expected to record a 30.5% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Cardiac AI Monitoring & Diagnostics Software segment is estimated at 25.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$346.6 Million While China is Forecast to Grow at 25.9% CAGR

The Cardiac Artificial Intelligence Monitoring and Diagnostics market in the U.S. is estimated at US$346.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$850.4 Million by the year 2030 trailing a CAGR of 25.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.5% and 23.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 18.7% CAGR.

Global Cardiac Artificial Intelligence Monitoring and Diagnostics Market - Key Trends & Drivers Summarized

Why Is the Demand for Cardiac Artificial Intelligence Monitoring and Diagnostics Increasing?

The demand for cardiac artificial intelligence monitoring and diagnostics is rising due to the increasing prevalence of cardiovascular diseases, the need for early and accurate detection, and advancements in AI-driven healthcare solutions. Heart diseases, including coronary artery disease, heart failure, and arrhythmias, remain the leading cause of mortality worldwide. Traditional diagnostic methods, while effective, often require time-consuming interpretation and are prone to human error. AI-powered monitoring systems and diagnostic tools are transforming cardiovascular care by providing faster, more precise, and real-time insights into heart health.

The rise of wearable health technology, remote patient monitoring, and AI-assisted imaging has made cardiac diagnostics more accessible and proactive. AI-powered ECG interpretation, predictive analytics for heart failure, and automated detection of arrhythmias are helping clinicians make informed decisions while reducing the burden on healthcare providers. Additionally, the integration of AI in telehealth and digital health platforms allows for early intervention, particularly in high-risk patients, reducing hospitalizations and improving patient outcomes. As healthcare systems shift towards predictive and preventive cardiology, the adoption of AI-driven cardiac diagnostics is expected to expand.

How Are Technological Advancements Improving Cardiac AI Monitoring and Diagnostics?

Innovations in artificial intelligence, deep learning, and wearable sensor technology are enhancing the accuracy, efficiency, and accessibility of cardiac monitoring and diagnostics. One of the most significant advancements is the development of AI-enhanced electrocardiograms (ECGs) that can detect complex cardiac conditions such as atrial fibrillation, ventricular tachycardia, and myocardial infarctions with high accuracy. AI-powered ECG algorithms can analyze vast amounts of data in real-time, reducing diagnostic errors and improving early detection rates.

Another major breakthrough is the integration of AI in cardiovascular imaging, including echocardiography, cardiac MRI, and CT angiography. AI-driven imaging solutions assist radiologists and cardiologists in identifying abnormalities, quantifying heart function, and assessing coronary artery disease more efficiently. Additionally, wearable AI-powered cardiac monitors, such as smartwatches and biosensors, provide continuous, real-time heart health monitoring, alerting users and healthcare providers to potential risks before symptoms become critical. Machine learning models are also being developed to predict heart disease progression and personalize treatment plans based on patient-specific data. As AI technology continues to evolve, its role in cardiac care will become even more prominent, improving accuracy, efficiency, and early disease detection.

Which Market Trends Are Driving Growth in the Cardiac AI Monitoring and Diagnostics Industry?

The increasing adoption of AI in telemedicine and remote patient monitoring is one of the most influential trends shaping the cardiac artificial intelligence market. With the rise of virtual healthcare, AI-powered cardiac monitoring devices are enabling continuous, at-home heart health tracking, reducing the need for frequent hospital visits. This trend is particularly important for managing chronic heart conditions and high-risk patients, as real-time AI analytics can help detect irregularities before they lead to severe complications.

Another key trend influencing market growth is the expansion of AI in personalized medicine. AI-driven analytics are being used to tailor treatment plans based on individual patient data, improving outcomes for those with heart disease. Additionally, pharmaceutical companies are leveraging AI to optimize drug discovery for cardiovascular treatments, further integrating AI into the broader ecosystem of cardiac care. The rise of big data in cardiology, along with cloud-based AI solutions, is enabling seamless data sharing and real-time collaboration between healthcare professionals, enhancing patient care. As AI-driven diagnostics continue to improve, they are increasingly being integrated into hospital workflows, making AI-powered cardiac monitoring a standard in cardiovascular healthcare.

What Are the Key Growth Drivers Shaping the Future of the Cardiac AI Monitoring and Diagnostics Market?

The growth in the cardiac artificial intelligence monitoring and diagnostics market is driven by several key factors, including rising cardiovascular disease prevalence, advancements in AI algorithms, and the expansion of digital health infrastructure. One of the primary growth drivers is the increasing burden of heart disease, prompting the need for early detection, predictive analytics, and continuous monitoring solutions. AI-driven diagnostic tools reduce the time required for heart disease diagnosis, allowing for faster interventions and improved patient outcomes.

Another crucial driver shaping the market is the increasing regulatory approvals and adoption of AI-powered diagnostic solutions by healthcare institutions. Governments and regulatory bodies are recognizing the potential of AI in cardiology, leading to greater investments in AI research and digital healthcare policies. Additionally, the affordability and accessibility of AI-driven wearables, coupled with improved AI interpretability, are making cardiac monitoring more patient-friendly and scalable. As AI integration in healthcare continues to accelerate, the cardiac AI monitoring and diagnostics market is expected to witness substantial growth, revolutionizing heart disease detection, prevention, and management worldwide.

SCOPE OF STUDY:

The report analyzes the Cardiac Artificial Intelligence Monitoring and Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Cardiac AI Monitoring and Diagnostics Hardware, Cardiac AI Monitoring and Diagnostics Software, Cardiac AI Monitoring and Diagnostics Services); Type (Cardiac Diagnostics, Cardiac Monitoring); Application (Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application, Stenosis Application, Other Applications); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Aidoc Medical Ltd.
  • AliveCor, Inc.
  • Arterys Inc.
  • Boston Scientific Corporation
  • CardiAI
  • Cardio Diagnostics
  • Cardiologs Technologies
  • Cleerly, Inc.
  • DiA Imaging Analysis
  • Eko Health Inc.
  • GE HealthCare Technologies Inc.
  • HeartVista, Inc.
  • Idoven
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • RSIP Vision
  • Siemens Healthineers AG
  • Tempus AI, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Cardiac Artificial Intelligence Monitoring and Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Cardiovascular Disease Burden Throws the Spotlight on AI-Powered Cardiac Monitoring Systems
    • Integration of AI in ECG, Imaging, and Wearables Propels Growth in Real-Time Diagnostic Capabilities
    • Early Detection and Risk Stratification Capabilities Expand the Addressable Market for AI Cardiac Tools
    • AI Algorithms for Arrhythmia, Heart Failure, and Ischemia Enhance Diagnostic Precision and Speed
    • Telecardiology Adoption Accelerates Demand for Remote AI-Driven Monitoring Platforms
    • Healthcare Shift Toward Predictive Analytics Strengthens the Business Case for AI Diagnostics
    • Wearable and Ambulatory Monitoring Devices Integrated with AI Spur Out-of-Hospital Cardiac Care Growth
    • Smart Hospitals and Digital Health Ecosystems Fuel Demand for AI-Based Clinical Decision Support Tools
    • AI-Powered Imaging Interpretation Drives Efficiency in Echocardiography and Cardiac MRI/CT Analysis
    • Regulatory Approvals of AI Software-as-Medical-Device (SaMD) Create New Commercial Pathways
    • Cardiology Workflow Optimization through AI Reduces Diagnostic Time and Clinical Burden
    • Collaborations Between MedTech and AI Startups Accelerate Product Innovation and Market Entry
    • Growing Role of AI in Population Health Management and Preventive Cardiology Supports Market Adoption
    • AI Model Transparency, Validation, and Explainability Become Critical in Regulatory and Clinical Acceptance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Artificial Intelligence Monitoring and Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cardiac Arrhythmias Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cardiac Arrhythmias Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Stroke Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Ischemic Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Ischemic Heart Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Cardiac Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Cardiac Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Cardiac Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Cardiac Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • JAPAN
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • CHINA
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • EUROPE
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • FRANCE
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • GERMANY
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • ITALY
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030

IV. COMPETITION